In breast cancer [18], gallbladder cancer [16], renal clear-cell cancer [19], esophageal squamous cell carcinoma [10], and lung cancer [20], methylation abnormalities in CDO1 have been reported as a prognostic factor. This evidence concerns the gene CDO1 and esophageal squamous cell carcinoma.